Johnson & Johnson's upcoming COVID-19 vaccine trials to include infants

Johnson & Johnson plans to test its coronavirus vaccine in infants and even in newborns, as well as in pregnant women and in people who have compromised immune systems. The bold plan for expanded clinical trials met with the approval of Dr Ofer Levy, director of the Precision Vaccines Program at Harvard’s Boston Children’s Hospital and a member of the Food and Drug Administration advisory committee that reviewed the company’s vaccine data. When Levy saw the outlines of the planned trials, "they turned my head," he said. They were reported as part of the company’s application to the FDA for emergency use approval and discussed at the FDA meeting.

“They did not get into a lot of detail about it but did make it clear they will be pursuing pediatric and maternal coronavirus immunization studies,” Levy said. They referred committee members to their briefing materials where, on page 34, the company mentioned the planned studies.

A spokesperson for Janssen Biotech, the Johnson & Johnson subsidiary that is manufacturing the vaccine, confirmed that the company planned to extend clinical trials to children.

PfizerBioNTech and Moderna, whose coronavirus vaccines are now being given to adults, plan to gradually test them in younger and younger age groups. Those vaccines are now being tested in children 12 and older.

Johnson & Johnson will first test its vaccine in children older than 12 and under 18, but plans to immediately after begin a study that includes newborns and adolescents. The company then will test its vaccine in pregnant women, and finally in immunocompromised people. Like the other companies, Johnson & Johnson will analyze safety and immune responses.

Unlike the COVID-19 vaccines currently in use, which use a new technology involving messenger RNA, the Johnson & Johnson vaccine utilizes a method that has been widely tested for years. It relies on a disabled adenovirus, similar to viruses that cause the common cold, to deliver instructions to cells to briefly make copies of the virus’s spike protein. The recipient’s immune system then makes antibodies against the spike protein. The coronavirus needs its spike proteins to infect cells, so the antibodies can block a COVID infection before it starts.

Existing adenovirus vaccines include one for Ebola that has been safely administered to babies as young as age 1, and another for respiratory syncytial virus that was safely given to newborns. Nearly 200,000 people have received adenovirus vaccines, with no serious safety issues, Levy said. He said that Johnson & Johnson mentioned that safety record at the FDA meeting.

Most of the world’s vaccine market is for pediatric vaccines.

Levy added that in his opinion children need not be immunized in order for schools to open. But many parents are afraid to send their children to school without a vaccine. And, he noted, vaccinating children will help the country reach herd immunity.

Gina Kolata. c.2021 The New York Times Company



from Firstpost Tech Latest News https://ift.tt/3kx2YL8

Comments

Post a Comment

Popular posts from this blog

Elon Musk’s bid spotlights Twitter’s unique role in public discourse – and what changes might be in store

Twitter has been in the news a lot lately, albeit for the wrong reasons. Its stock growth has languished and the platform itself has largely remained the same since its founding in 2006. On April 14, 2022, Elon Musk, the world’s richest person, made an offer to buy Twitter and take the public company private. In a filing with the Securities and Exchange Commission , Musk stated, “I invested in Twitter as I believe in its potential to be the platform for free speech around the globe, and I believe free speech is a societal imperative for a functioning democracy.” As a researcher of social media platforms , I find that Musk’s potential ownership of Twitter and his stated reasons for buying the company raise important issues. Those issues stem from the nature of the social media platform and what sets it apart from others. What makes Twitter unique Twitter occupies a unique niche. Its short chunks of text and threading foster real-time conversations among thousands of people, which
Read more

To reach net-zero emissions and remove CO2 from the air, scientists drawn up six priorities

Image
To reach net-zero emissions by 2050, global emissions must be cut faster and deeper than the world has yet managed. But even then, some hard-to-treat sources of pollution – in aviation, agriculture and cement making – may linger for longer than we would like. It will take time for clean alternatives to arrive and replace them. That means the world also needs to find and ramp up ways of taking CO₂ out of the atmosphere to stabilise the climate. Just meeting the UK’s net-zero target is likely to require the removal of 100 million tonnes of CO₂ a year , similar in size to current emissions from the country’s largest-emitting sector, road transport, but in reverse. The UK government’s announcement of £31.5 million (US$44.7 million) in support for research and development of carbon removal is welcome. And while trials of new tech will help, there are many social issues that need to be tackled if removing greenhouse gases is to succeed. Done right, carbon removal could be the perfect a
Read more

NASA is planning to partner with SpaceX to reboost the Hubble Telescope and extend its life

Image
The Hubble Space Telescope is one of the most important scientific achievements of the human species that has helped us understand space. It has been in orbit for over 30 years and has been feeding some of the most vital streams of information that has not only helped us steer our space exploration efforts, but also solve some of the more deep mysteries of the universe . NASA would love to extend its usable life for as long as possible. Unfortunately, for some years now, Hubble Space Telescope has been slipping out of its orbit. That is why, NASA is planning to team up with Elon Musk’s SpaceX and place it into a higher much more stable orbit. NASA, SpaceX and Jared Isaacman, a private astronaut with the Polaris Program, hosted a media teleconference on Thursday to announce a feasibility study that will look into sending a commercial Dragon spacecraft to reboost the Hubble Space Telescope . This will, in effect place the telescope into a higher and more stable orbit than it’s curren
Read more